Biocompatible nanocomposite for PET/MRI hybrid imaging

Citations of this article
Mendeley users who have this article in their library.


A novel nanocarrier system was designed and developed with key components uniquely structured at the nanoscale for early cancer diagnosis and treatment. In order to perform magnetic resonance imaging, hydrophilic superparamagnetic maghemite nanoparticles (NPs) were synthesized and coated with a lipophilic organic ligand. Next, they were entrapped into polymeric NPs made of biodegradable poly(lactic-co-glycolic acid) linked to polyethylene glycol. In addition, resulting NPs have been conjugated on their surface with a 2,2'-(7-(4-((2-aminoethyl)amino)-1-carboxy-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic acid ligand for subsequent 68Ga incorporation. A cell-based cytotoxicity assay has been employed to verify the in vitro cell viability of human pancreatic cancer cells exposed to this nanosystem. Finally, in vivo positron emission tomography-computerized tomography biodistribution studies in healthy animals were performed. © 2012 Locatelli et al, publisher and licensee Dove Medical Press Ltd.




Locatelli, E., Gil, L., Israel, L. L., Passoni, L., Naddaka, M., Pucci, A., … Comes Franchini, M. (2012). Biocompatible nanocomposite for PET/MRI hybrid imaging. International Journal of Nanomedicine, 7, 6021–6033.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free